Stocks and Investing Stocks and Investing
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022
Thu, May 19, 2022

Christopher Raymond Maintained (ALXO) at Buy with Decreased Target to $48 on, May 19th, 2022


Published on 2024-10-27 21:10:47 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Decreased Target from $70 to $48 on, May 19th, 2022.

Christopher has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $36 on, Tuesday, March 1st, 2022